PneumoniaNCT06732739
Combined Effects of Breathing Teach Back Training And Percussion In Patients With Pneumonia
A study testing percussions with teach-back breathing exercise and PERCUSSION in people with Pneumonia, run by Riphah International University at 1 site in Pakistan.
Trial summary
Pneumonia, marked by lung inflammation, leads to symptoms like fever and difficulty breathing, affecting millions globally. It particularly impacts children and the elderly. Lung function is altered, reducing capacities and obstructing airflow. Read more about this study
- Who is it for?
- Ages 35 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Pneumonia
- What is being tested?
- percussions with teach-back breathing exercise and PERCUSSION
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 sitePakistan
- Study dates
- 30 Aug 2024to 1 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Both genders
- Age 35-45 years
- Diagnosed pneumonia
Who cannot join
- History of neurological disorders
- History of fractures
- History of other pulmonary complications (15)
- Patients having any chest infection will be excluded
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Social Security Hospital Lahore
Lahore, Punjab Province, 54000
About this study
Official title: Combined Effects of Breathing Teach Back Training And Percussion On Pulmonary Functions In Patients With Pneumonia
Pneumonia, marked by lung inflammation, leads to symptoms like fever and difficulty breathing, affecting millions globally. It particularly impacts children and the elderly. Lung function is altered, reducing capacities and obstructing airflow. Post-recovery, patients may experience dyspnea due to lingering fluids-deep breathing exercises, using teach-back training, aid rehabilitation. Combining teach-back with chest percussion in physiotherapy aims to enhance respiratory outcomes in pneumonia patients. This will be a randomized clinical trial sample size calculated by epitool sample size calculator which is 30 patients 15 in each group. Regular chest percussion involves a clapping technique in five drainage positions, with assisted suction. Teach-back breathing exercises will also be implemented in this group In Group A, individuals will perform teach-back breathing exercises with chest percussion. In Group B, a similar protocol will be followed without the teach-back breathing exercises. Data analysis, using SPSS version 21, will include the Shapiro-Wilk Test for normality assessment. Descriptive statistics, paired sample t-tests, Wilcoxon signed-rank tests, independent sample t-tests, and Mann-Whitney U tests will be employed to analyze group measurements, changes over time, and differences between groups. This comprehensive approach aims to provide a thorough understanding of the study variables and measurements.
- Conditions
- Pneumonia
- Being tested
- percussions with teach-back breathing exercise, PERCUSSION
- Keywords
- Pneumonia, Percussion, Modified Borg Scale
- Medical subject headings
- Pneumonia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
percussions with teach-back breathing exerciseOther
patient will receive Teach Back Breathing Exercises like pursed lip breathing, DE breathing and diaphragmatic breathing Teach-back breathing exercises refer to a method of instructing individuals in breathing techniques and then having them demonstrate or "teach back" the instructions to ensure comprehension and mastery. This educational approach is commonly used in healthcare settings, particularly when teaching patients how to perform various breathing exercises for therapeutic purposes. Patients were informed about the importance of regular chest percussion I will use the clapping technique which provided by cupped hand for 3 minutes in 5 positions of drainage (upper lobes-apical and posterior segment, apical and anterior segment, right upper lobe-posterior segment, left upper lobe-posterior segment, lower lobes- apical segment) with assisted suction three times/shift for four days, and then each patient will be observed.
PERCUSSIONOther
similar to Group A, each patient underwent individual interviews. Patients were educated on the significance of regular chest percussion. The clapping technique, executed with cupped hands, was applied for 3 minutes in five drainage positions (upper lobes - apical and posterior segment, apical and anterior segment, right upper lobe - posterior segment, left upper lobe - posterior segment, lower lobes - apical segment). This procedure, including assisted suction three times per shift, was administered for four consecutive days.
| Study group | Role | What they receive |
|---|---|---|
| percussions with teach-back breathing exercises | Experimental | The treatment will be given with the frequency of 3 times per week for 8 weeks. Treatment sessions will be 25 to 30 minutes with short resting intervals. Receives: Other: percussions with teach-back breathing exercise; Other: PERCUSSION |
| percussions | Active comparator | The treatment will be given with the frequency of 3 times per week for 8 weeks. Treatment sessions will be 25 to 30 minutes with short resting intervals. Receives: Other: PERCUSSION |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pulmonary functions test
A pulmonary function test (PFT) is a diagnostic assessment that evaluates the functional capacity of the respiratory system, providing valuable information about lung volumes, capacities, and the efficiency of gas exchange. These tests are crucial for diagnosing and monitoring respiratory conditions such as asthma, chronic obstructive pulmonary disease , and restrictive lung diseases, Pulmonary function test Normal values are FEV1 80% to 120%, FVC 80% to 120%. Absolute FEV1 /FVC ratio, Within 5% of the predicted ratio, TLC 80% to 120%
Measured: baseline and fourth week
SF 36
The SF-36, or Short Form 36, is a widely used questionnaire designed to assess an individual's health-related quality of life. It encompasses 36 questions across eight health domains, providing insights into various aspects of physical and mental well-being. The questionnaire covers areas such as physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Measured: baseline and fourth week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Dec 2024
- Study start30 Aug 2024
- Primary completion15 Nov 2024
- Study completion1 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for PneumoniaStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sidra Afzal, PP-DPT, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06732739
- Sponsor's protocol ID
- REC/RCR&AHS/23/0370
- Status last verified
- Dec 2024
- First submitted
- 13 Aug 2024
- Last updated
- 13 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Morris AM, Huang L, Bacchetti P, Turner J, Hopewell PC, Wallace JM, Kvale PA, Rosen MJ, Glassroth J, Reichman LB, Stansell JD. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):612-6. doi: 10.1164/ajrccm.162.2.9912058.
PubMed 10934095Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H; WHO Child Health Epidemiology Reference Group. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004 Dec;82(12):895-903. Epub 2005 Jan 5.
PubMed 15654403Hogan DR, Stevens GA, Hosseinpoor AR, Boerma T. Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services. Lancet Glob Health. 2018 Feb;6(2):e152-e168. doi: 10.1016/S2214-109X(17)30472-2. Epub 2017 Dec 13.
PubMed 29248365
Study at a glance
From the registry record, last updated by the sponsor on 13 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Combined Effects of Breathing Teach Back Training And Percussion On Pulmonary Functions In Patients With Pneumonia
- ClinicalTrials.gov ID
- NCT06732739
- Acronym / sponsor ID
- REC/RCR&AHS/23/0370
- Conditions
- Pneumonia
- Keywords
- Pneumonia, Percussion, Modified Borg Scale
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 30 Aug 2024 (actual)
- Primary completion
- 15 Nov 2024 (actual)
- Study completion
- 1 Dec 2024 (actual)
- First posted
- 13 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pneumonia, marked by lung inflammation, leads to symptoms like fever and difficulty breathing, affecting millions globally. It particularly impacts children and the elderly. Lung function is altered, reducing capacities and obstructing airflow. Post-recovery, patients may experience dyspnea due to lingering fluids-deep breathing exercises, using teach-back training, aid rehabilitation. Combining teach-back with chest percussion in physiotherapy aims to enhance respiratory outcomes in pneumonia patients. This will be a randomized clinical trial sample size calculated by epitool sample size calculator which is 30 patients 15 in each group. Regular chest percussion involves a clapping technique in five drainage positions, with assisted suction. Teach-back breathing exercises will also be implemented in this group In Group A, individuals will perform teach-back breathing exercises with chest percussion. In Group B, a similar protocol will be followed without the teach-back breathing exercises. Data analysis, using SPSS version 21, will include the Shapiro-Wilk Test for normality assessment. Descriptive statistics, paired sample t-tests, Wilcoxon signed-rank tests, independent sample t-tests, and Mann-Whitney U tests will be employed to analyze group measurements, changes over time, and differences between groups. This comprehensive approach aims to provide a thorough understanding of the study variables and measurements.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| percussions with teach-back breathing exercises | Experimental | Other: percussions with teach-back breathing exercise, Other: PERCUSSIONThe treatment will be given with the frequency of 3 times per week for 8 weeks. Treatment sessions will be 25 to 30 minutes with short resting intervals. |
| percussions | Active comparator | Other: PERCUSSIONThe treatment will be given with the frequency of 3 times per week for 8 weeks. Treatment sessions will be 25 to 30 minutes with short resting intervals. |
Who may qualify
- Ages
- 35 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Both genders
- Age 35-45 years
- Diagnosed pneumonia
Key exclusion criteria (4 listed)
- History of neurological disorders
- History of fractures
- History of other pulmonary complications (15)
- Patients having any chest infection will be excluded
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| percussions with teach-back breathing exercisepatient will receive Teach Back Breathing Exercises like pursed lip breathing, DE breathing and diaphragmatic breathing Teach-back breathing exercises refer to a method of instructing individuals in breathing techniques and then having them demonstrate or "teach back" the instructions to ensure comprehension and mastery. This educational approach is commonly used in healthcare settings, particularly when teaching patients how to perform various breathing exercises for therapeutic purposes. Patients were informed about the importance of regular chest percussion I will use the clapping technique which provided by cupped hand for 3 minutes in 5 positions of drainage (upper lobes-apical and posterior segment, apical and anterior segment, right upper lobe-posterior segment, left upper lobe-posterior segment, lower lobes- apical segment) with assisted suction three times/shift for four days, and then each patient will be observed. | Other | percussions with teach-back breathing exercises |
| PERCUSSIONsimilar to Group A, each patient underwent individual interviews. Patients were educated on the significance of regular chest percussion. The clapping technique, executed with cupped hands, was applied for 3 minutes in five drainage positions (upper lobes - apical and posterior segment, apical and anterior segment, right upper lobe - posterior segment, left upper lobe - posterior segment, lower lobes - apical segment). This procedure, including assisted suction three times per shift, was administered for four consecutive days. | Other | percussions, percussions with teach-back breathing exercises |
Primary outcome
Pulmonary functions test
Time frame: baseline and fourth week
A pulmonary function test (PFT) is a diagnostic assessment that evaluates the functional capacity of the respiratory system, providing valuable information about lung volumes, capacities, and the efficiency of gas exchange. These tests are crucial for diagnosing and monitoring respiratory conditions such as asthma, chronic obstructive pulmonary disease , and restrictive lung diseases, Pulmonary function test Normal values are FEV1 80% to 120%, FVC 80% to 120%. Absolute FEV1 /FVC ratio, Within 5% of the predicted ratio, TLC 80% to 120%
SF 36
Time frame: baseline and fourth week
The SF-36, or Short Form 36, is a widely used questionnaire designed to assess an individual's health-related quality of life. It encompasses 36 questions across eight health domains, providing insights into various aspects of physical and mental well-being. The questionnaire covers areas such as physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Dec 2024.
- Background: PubMed 10934095Morris AM, Huang L, Bacchetti P, Turner J, Hopewell PC, Wallace JM, Kvale PA, Rosen MJ, Glassroth J, Reichman LB, Stansell JD. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):612-6. doi: 10.1164/ajrccm.162.2.9912058.
- Background: PubMed 15654403Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H; WHO Child Health Epidemiology Reference Group. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004 Dec;82(12):895-903. Epub 2005 Jan 5.
- Background: PubMed 29248365Hogan DR, Stevens GA, Hosseinpoor AR, Boerma T. Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services. Lancet Glob Health. 2018 Feb;6(2):e152-e168. doi: 10.1016/S2214-109X(17)30472-2. Epub 2017 Dec 13.
- Individual participant dataSharing planned: No
Related trials for Pneumonia
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not yet recruiting
Expanded Diagnostic Strategy in Older Adults Hospitalized With Community-Acquired Acute Respiratory Infection
Acute Respiratory Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sidra Afzal, PP-DPT principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing percussions with teach-back breathing exercise and PERCUSSION in people with Pneumonia, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pulmonary functions test (time frame: baseline and fourth week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06732739, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2024.